Peak Bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
15.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-06-30
|
0.00
|
-0.09
|
0.00
|
0.00%
|
|
2024-03-31
|
0.00
|
-0.11
|
0.00
|
0.00%
|
|
2023-12-31
|
0.00
|
-0.02
|
0.00
|
0.00%
|
|
2023-09-30
|
0.00
|
0.01
|
0.00
|
0.00%
|
|
2023-06-30
|
0.00
|
-0.29
|
0.00
|
0.00%
|
|
2023-03-31
|
0.00
|
-0.34
|
0.00
|
0.00%
|
|
2022-12-31
|
0.00
|
-0.75
|
0.00
|
0.00%
|
|
2022-09-30
|
-0.46
|
-0.02
|
0.44
|
95.65%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-06-30
|
-0.20
|
|
2023-12-31
|
-0.65
|
|
2022-12-31
|
-0.76
|
|
2021-12-31
|
-0.20
|